Literature DB >> 1925546

Neuronal activity in narcolepsy: identification of cataplexy-related cells in the medial medulla.

J M Siegel1, R Nienhuis, H M Fahringer, R Paul, P Shiromani, W C Dement, E Mignot, C Chiu.   

Abstract

Narcolepsy is a neurological disorder characterized by sleepiness and episodes of cataplexy. Cataplexy is an abrupt loss of muscle tone, most often triggered by sudden, strong emotions. A subset of cells in the medial medulla of the narcoleptic dog discharged at high rates only in cataplexy and rapid eye movement (REM) sleep. These cells were noncholinergic and were localized to ventromedial and caudal portions of the nucleus magnocellularis. The localization and discharge pattern of these cells indicate that cataplexy results from a triggering in waking of the neurons responsible for the suppression of muscle tone in REM sleep. However, most medullary cells were inactive during cataplexy but were active during REM sleep. These data demonstrate that cataplexy is a distinct behavioral state, differing from other sleep and waking states in its pattern of brainstem neuronal activity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1925546      PMCID: PMC8784798          DOI: 10.1126/science.1925546

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  19 in total

1.  NOCTURNAL SLEEP OF NARCOLEPTICS.

Authors:  A RECHTSCHAFFEN; E A WOLPERT; W C DEMENT; S A MITCHELL; C FISHER
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1963-08

2.  Neuronal activity specific to REM sleep and its relationship to breathing.

Authors:  A Netick; J Orem; W Dement
Journal:  Brain Res       Date:  1977-01-21       Impact factor: 3.252

3.  Muscarinic cholinergic receptors and the canine model of narcolepsy.

Authors:  T S Kilduff; S S Bowersox; K I Kaitin; T L Baker; R D Ciaranello; W C Dement
Journal:  Sleep       Date:  1986       Impact factor: 5.849

4.  Inhibitory effects evoked through ventral reticulospinal pathways.

Authors:  E Jankowska; S Lund; A Lundberg; O Pompeiano
Journal:  Arch Ital Biol       Date:  1968-05       Impact factor: 1.000

5.  Prazosin contraindicated in patients with narcolepsy.

Authors:  C Guilleminault; E Mignot; M Aldrich; M A Quera-Salva; M Tiberge; M Partinen
Journal:  Lancet       Date:  1988-08-27       Impact factor: 79.321

6.  Medullary regions mediating atonia.

Authors:  Y Y Lai; J M Siegel
Journal:  J Neurosci       Date:  1988-12       Impact factor: 6.167

7.  Distribution of choline acetyltransferase immunoreactive somata in the feline brainstem: implications for REM sleep generation.

Authors:  P J Shiromani; D M Armstrong; A Berkowitz; D V Jeste; J C Gillin
Journal:  Sleep       Date:  1988-02       Impact factor: 5.849

8.  Activity of medullary reticular formation neurons in the unrestrained cat during waking and sleep.

Authors:  J M Siegel; R L Wheeler; D J McGinty
Journal:  Brain Res       Date:  1979-12-21       Impact factor: 3.252

9.  Role of pontomedullary reticular formation neurons in horizontal head movements: an ibotenic acid lesion study in the cat.

Authors:  S S Suzuki; J M Siegel; M F Wu
Journal:  Brain Res       Date:  1989-04-10       Impact factor: 3.610

10.  Behavioral relations of medullary reticular formation cells.

Authors:  J M Siegel
Journal:  Exp Neurol       Date:  1979-09       Impact factor: 5.620

View more
  64 in total

1.  Activation of pontine and medullary motor inhibitory regions reduces discharge in neurons located in the locus coeruleus and the anatomical equivalent of the midbrain locomotor region.

Authors:  B Y Mileykovskiy; L I Kiyashchenko; T Kodama; Y Y Lai; J M Siegel
Journal:  J Neurosci       Date:  2000-11-15       Impact factor: 6.167

2.  Cessation of activity in red nucleus neurons during stimulation of the medial medulla in decerebrate rats.

Authors:  Boris Y Mileykovskiy; Lyudmila I Kiyashchenko; Jerome M Siegel
Journal:  J Physiol       Date:  2002-12-15       Impact factor: 5.182

3.  Release of hypocretin (orexin) during waking and sleep states.

Authors:  Lyudmila I Kiyashchenko; Boris Y Mileykovskiy; Nigel Maidment; Hoa A Lam; Ming-Fung Wu; Joshi John; John Peever; Jerome M Siegel
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

4.  Molecular cloning, chromosomal mapping, and functional expression of human brain glutamate receptors.

Authors:  W Sun; A V Ferrer-Montiel; A F Schinder; J P McPherson; G A Evans; M Montal
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

Review 5.  Neurobiological and immunogenetic aspects of narcolepsy: Implications for pharmacotherapy.

Authors:  Steven T Szabo; Michael J Thorpy; Geert Mayer; John H Peever; Thomas S Kilduff
Journal:  Sleep Med Rev       Date:  2018-11-08       Impact factor: 11.609

6.  Behavioral correlates of activity in identified hypocretin/orexin neurons.

Authors:  Boris Y Mileykovskiy; Lyudmila I Kiyashchenko; Jerome M Siegel
Journal:  Neuron       Date:  2005-06-02       Impact factor: 17.173

Review 7.  Rapid eye movement sleep behavior disorder and the link to alpha-synucleinopathies.

Authors:  Daniel A Barone; Claire Henchcliffe
Journal:  Clin Neurophysiol       Date:  2018-05-29       Impact factor: 3.708

8.  The echidna Tachyglossus aculeatus combines REM and non-REM aspects in a single sleep state: implications for the evolution of sleep.

Authors:  J M Siegel; P R Manger; R Nienhuis; H M Fahringer; J D Pettigrew
Journal:  J Neurosci       Date:  1996-05-15       Impact factor: 6.167

9.  A Discrete Glycinergic Neuronal Population in the Ventromedial Medulla That Induces Muscle Atonia during REM Sleep and Cataplexy in Mice.

Authors:  Shuntaro Uchida; Shingo Soya; Yuki C Saito; Arisa Hirano; Keisuke Koga; Makoto Tsuda; Manabu Abe; Kenji Sakimura; Takeshi Sakurai
Journal:  J Neurosci       Date:  2020-12-28       Impact factor: 6.167

10.  A consensus definition of cataplexy in mouse models of narcolepsy.

Authors:  Thomas E Scammell; Jon T Willie; Christian Guilleminault; Jerome M Siegel
Journal:  Sleep       Date:  2009-01       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.